{Reference Type}: Case Reports
{Title}: Tigecycline-induced pancreatitis in a patient with recurrent malignancy: a case report and literature review.
{Author}: Arafat H;Sadaqa D;Sabateen A;
{Journal}: Ann Med Surg (Lond)
{Volume}: 86
{Issue}: 6
{Year}: 2024 Jun
暂无{DOI}: 10.1097/MS9.0000000000002077
{Abstract}: <B>UNASSIGNED: </B>Drug-induced pancreatitis is an important health issue that makes a minority of causes of acute pancreatitis. Tigecycline-induced pancreatitis is a rare condition with poorly understood mechanism and has a small incident compared to other causes of pancreatitis.<BR><B>UNASSIGNED: </B>The authors present a case of a 39-year-old female patient with acute pancreatitis. Tigecycline was the suspected culprit by exclusion. The patient was managed by keeping her nill per os, rehydration, pain management and discontinuation of the drug. The patient improved gradually.<BR><B>UNASSIGNED: </B>Tigecycline-induced acute pancreatitis is a rare but known complication that is mostly seen in patients with chronic renal insufficiency combined with high dose of administration. Onset is usually within 14 days of initiation. Discontinuation of the drug is the most effective intervention in addition to supportive management.<BR><B>UNASSIGNED: </B>Acute pancreatitis should be suspected in any patient presenting with vomiting, abdominal pain and acidosis while on tigecycline. Monitoring of amylase and lipase can be beneficial especially in those with chronic renal insufficiency or those receiving a high dose.